Home › NDC Lookup › RxCUI directory › RxCUI 311880

Mycophenolate mofetil 200 MG/ML Oral Suspension — RxCUI 311880

RxNorm drug concept · Semantic clinical drug
RxCUI 311880 Semantic clinical drug · SCD ● Current RxNorm concept 13 FDA products 15 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI311880
Official nameMycophenolate mofetil 200 MG/ML Oral Suspension
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asmycophenolate mofetil 200 MG per 1 ML Oral Suspension; mycophenolate mofetil 200 MG in 1 mL Oral Suspension
FDA products mapped13
Package NDCs mapped15
Reported Medicaid activity (SDUD)20,021 prescriptions · 44 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Mycophenolate Mofetil: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • It helps keep your body from rejecting a transplanted kidney, heart or liver. You take it together with other immunosuppressant medicines. It works by calming the immune cells that...
  • It's usually taken twice a day, by mouth as a capsule, tablet or liquid, or through an IV in the hospital. Follow your prescriber's directions and your label. Don't switch it with...
  • Diarrhea, nausea, vomiting and stomach pain are common. Call your doctor if you have a fever, chills or other signs of infection, unusual bruising or bleeding, black stools, severe...
  • What side effects are normal, and when should I call?
📖 Read our full Mycophenolate Mofetil guide →

🕸️ Concept Web — How Mycophenolate mofetil 200 MG/ML Oral Suspension Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Mycophenolate mofetil 200 MG/ML Oral Suspension RxCUI 311880

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Mycophenolate mofetil 68149
  2. Brand names 2

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Cellcept 152633
    • Myhibbin 2684846
  3. Dose forms 12

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Mycophenolate mofetil Oral Suspension 374670
    • Mycophenolate mofetil Oral Liquid Product 1157870
    • Mycophenolate mofetil Oral Product 1157871
    • Mycophenolate mofetil Oral Suspension [Cellcept] 616443
    • Mycophenolate mofetil Oral Suspension [Myhibbin] 2684850
    • Cellcept Oral Liquid Product 1166214
    • Cellcept Oral Product 1166215
    • Myhibbin Oral Liquid Product 2684849
    • +4 more in this family
  4. Clinical & branded drugs 5

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 16 of 20 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Mycophenolate mofetil 200 MG/ML SCDC · 331587
  • Mycophenolate mofetil Oral Suspension SCDF · 374670
  • Mycophenolate mofetil Oral Liquid Product SCDG · 1157870
  • Mycophenolate mofetil Oral Product SCDG · 1157871

Brand-Name Concepts

📦 FDA Products & Package NDCs

13 products · 15 package NDCs
15 package NDCs map to RxCUI 311880 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
00004-0259-01 1 BOTTLE, PLASTIC in 1 CARTON (0004-0259-01) / 100 CAPSULE... CellCept Genentech, Inc. 1995-05-03
00004-0259-43 1 BOTTLE, PLASTIC in 1 CARTON (0004-0259-43) / 500 CAPSULE... CellCept Genentech, Inc. 1995-05-03
00004-0260-01 1 BOTTLE, PLASTIC in 1 CARTON (0004-0260-01) / 100 TABLET,... CellCept Genentech, Inc. 1997-06-19
00004-0260-43 1 BOTTLE, PLASTIC in 1 CARTON (0004-0260-43) / 500 TABLET,... CellCept Genentech, Inc. 1997-06-19
00004-0261-29 1 BOTTLE, PLASTIC in 1 CARTON (0004-0261-29) / 225 mL in 1... CellCept Genentech, Inc. 1998-10-01
00004-0298-09 4 VIAL in 1 CARTON (0004-0298-09) / 20 mL in 1 VIAL CellCept Genentech, Inc. 1998-08-12
00527-5160-82 1 BOTTLE, PLASTIC in 1 CARTON (0527-5160-82) / 225 mL in 1... Mycophenolate Mofetil Lannett Company, Inc. 2021-07-29
23155-0848-51 1 BOTTLE, PLASTIC in 1 CARTON (23155-848-51) / 225 mL in 1... MYCOPHENOLATE MOFETIL Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. 2023-09-05
24338-0018-01 1 BOTTLE, PLASTIC in 1 CARTON (24338-018-01) / 175 mL in 1... MYHIBBIN Azurity Pharmaceuticals, Inc. 2024-06-10
59651-0646-26 1 BOTTLE in 1 CARTON (59651-646-26) / 225 mL in 1 BOTTLE MYCOPHENOLATE MOFETIL Aurobindo Pharma Limited 2024-09-26
60219-1595-02 1 BOTTLE, PLASTIC in 1 CARTON (60219-1595-2) / 225 mL in 1... Mycophenolate Mofetil Amneal Pharmaceuticals NY LLC 2024-03-21
66689-0307-08 1 BOTTLE, PLASTIC in 1 CARTON (66689-307-08) / 250 mL in 1... Mycophenolate Mofetil VistaPharm, LLC 2019-02-15
67877-0230-22 1 BOTTLE, PLASTIC in 1 CARTON (67877-230-22) / 225 mL in 1... Mycophenolate mofetil Ascend Laboratories, LLC 2014-11-17
69238-1595-02 1 BOTTLE, PLASTIC in 1 CARTON (69238-1595-2) / 225 mL in 1... Mycophenolate Mofetil Amneal Pharmaceuticals NY LLC 2021-11-05
72603-0751-01 1 BOTTLE in 1 CARTON (72603-751-01) / 225 mL in 1 BOTTLE MYCOPHENOLATE MOFETIL NorthStar Rx LLC 2026-03-01
Observed labelers: Genentech, Inc. (6) · Amneal Pharmaceuticals NY LLC (2) · Ascend Laboratories, LLC (1) · Aurobindo Pharma Limited (1) · Azurity Pharmaceuticals, Inc. (1) · Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. (1) · +3 more — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🧾 Billing Codes (HCPCS)

Medical billing codes (HCPCS "J-codes") that connect to this concept's packages — used mostly when a clinic or hospital bills for a drug it administers. Each code links to its full billing page.
CodeDescriptorMapped packagesSources
J7517 Mycophenolate mofetil oral 5 CMS
J7528 Mycophen mofetil for susp 4 CMS
J7514 Mycophenol (myhibbin) 100 mg 1 CMS
J7519 Inj. mycophenolate mofetil 1 CMS
⚠ A crosswalk is not coverage: an NDC↔HCPCS mapping does not guarantee any payer covers or pays the code. Always verify the current payer policy before billing.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.